Drugs / 123 iodine metaiodobenzylguanidine
123 iodine metaiodobenzylguanidine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01522378 | Feb 2012 → Feb 2016 | congestive heart failure | Mayo Clinic | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 123 iodine metaiodobenzylguanidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01522378 ↗ |
| Modality | Diagnostic / imaging agent | “123I-MIBG imaging” NCT01522378 ↗ |